Drugs of Abuse Testing

Introduction

September 2009

Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussion of current topics and may be helpful to you in your practice.

Our presenter for this program is Dr. Loralie Langman, a consultant from the Division of Clinical Biochemistry & Immunology and Associate Professor of Laboratory Medicine and Pathology in the College of Medicine. Dr. Langman is also the director of the Toxicology and Drug Monitoring Laboratory at Mayo Clinic in Rochester, Minnesota.

Dr. Langman will discuss the prevalence of illicit drug use in the United States and describe testing for commonly encountered drugs of abuse. She will also review drug detection limits, confirmation cutoffs, drug metabolism, and interpretation of screening and confirmation drug testing.

Introduction

Next Slide >

 

Jump to section:

• Objectives
• Drug Use
• Drug Testing
• Drug Metabolism
• Interpretation
• Summary
• Questions